http://www.nextprot.org/nanopubs#NX_Q01844-5_PTM-0066_577.RABA-ZBMHl3Cdor9Iljzrc8c_Hr2Qg8Q1XqiwVd0LZB4k
type: Nanopublication
created: 2014-09-19T00:00:00.0Z
rights: http://creativecommons.org/licenses/by/3.0/
rights holder: nextprot.org
used data: neXtProt database
authored by: CALIPHO project
authored by: http://orcid.org/0000-0001-6710-1373
authored by: 0000-0001-6818-334X
authored by: http://orcid.org/0000-0002-1303-2189
authored by: http://orcid.org/0000-0003-1813-6857
version number: 1

http://www.nextprot.org/nanopubs#NX_Q01844-5_PTM-0066_577.RABA-ZBMHl3Cdor9Iljzrc8c_Hr2Qg8Q1XqiwVd0LZB4k._2
SIO_000300: 577
type: StartPosition

http://www.nextprot.org/nanopubs#NX_Q01844-5_PTM-0066_577.RABA-ZBMHl3Cdor9Iljzrc8c_Hr2Qg8Q1XqiwVd0LZB4k._3
SIO_000300: 577
type: EndPosition

http://www.nextprot.org/nanopubs#NX_Q01844-5_PTM-0066_577.RABA-ZBMHl3Cdor9Iljzrc8c_Hr2Qg8Q1XqiwVd0LZB4k.assertion
comment: Asymmetric dimethylarginine; alternate; by PRMT8 modification of amino acid 577 of NX_Q01844-5
evidence: gold
primary source: prot.22004
primary source: jbc.M011446200
primary source: http://www.ncbi.nlm.nih.gov/pubmed/11278906
primary source: http://www.ncbi.nlm.nih.gov/pubmed/18320585

neXtProt gold
type: ECO_0000205